REPORT ID 4721

Global Glomerulonephritis Treatment Sales Market Report 2017

Publish Date
19-Dec-17
Pages
112
Format
Electronic (PDF)

In this report, the global Glomerulonephritis Treatment market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Glomerulonephritis Treatment for these regions, from 2012 to 2022 (forecast), covering
    United States
    China
    Europe
    Japan
    Southeast Asia
    India

Global Glomerulonephritis Treatment market competition by top manufacturers/players, with Glomerulonephritis Treatment sales volume, Price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Achillion Pharmaceuticals Inc
    Anthera Pharmaceuticals Inc
    Biogen Inc
    Bristol-Myers Squibb Company
    Cellmid Ltd
    ChemoCentryx Inc
    Complexa Inc
    Dimerix Bioscience Pty Ltd
    GlaxoSmithKline Plc
    Merck KGaA
    Omeros Corp
    Pfizer Inc
    Pharmalink AB
    Ra Pharmaceuticals Inc
    Retrophin Inc
    Rigel Pharmaceuticals Inc
    Shire Plc
    Visterra Inc
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    ACH-5228
    AMY-101
    Atacicept
    Avacopan
    AVX-002
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Home Care
    Clinic
    Hospital

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Glomerulonephritis Treatment Sales Market Report 2017
1 Glomerulonephritis Treatment Market Overview
    1.1 Product Overview and Scope of Glomerulonephritis Treatment
    1.2 Classification of Glomerulonephritis Treatment by Product Category
        1.2.1 Global Glomerulonephritis Treatment Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 Global Glomerulonephritis Treatment Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 ACH-5228
        1.2.4 AMY-101
        1.2.5 Atacicept
        1.2.6 Avacopan
        1.2.7 AVX-002
    1.3 Global Glomerulonephritis Treatment Market by Application/End Users
        1.3.1 Global Glomerulonephritis Treatment Sales (Volume) and Market Share Comparison by Application (2012-2022)
        1.3.2 Home Care
        1.3.3 Clinic
        1.3.4 Hospital
    1.4 Global Glomerulonephritis Treatment Market by Region
        1.4.1 Global Glomerulonephritis Treatment Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 United States Glomerulonephritis Treatment Status and Prospect (2012-2022)
        1.4.3 China Glomerulonephritis Treatment Status and Prospect (2012-2022)
        1.4.4 Europe Glomerulonephritis Treatment Status and Prospect (2012-2022)
        1.4.5 Japan Glomerulonephritis Treatment Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Glomerulonephritis Treatment Status and Prospect (2012-2022)
        1.4.7 India Glomerulonephritis Treatment Status and Prospect (2012-2022)
    1.5 Global Market Size (Value and Volume) of Glomerulonephritis Treatment (2012-2022)
        1.5.1 Global Glomerulonephritis Treatment Sales and Growth Rate (2012-2022)
        1.5.2 Global Glomerulonephritis Treatment Revenue and Growth Rate (2012-2022)

2 Global Glomerulonephritis Treatment Competition by Players/Suppliers, Type and Application
     2.1 Global Glomerulonephritis Treatment Market Competition by Players/Suppliers
        2.1.1 Global Glomerulonephritis Treatment Sales and Market Share of Key Players/Suppliers (2012-2017)
        2.1.2 Global Glomerulonephritis Treatment Revenue and Share by Players/Suppliers (2012-2017)
    2.2 Global Glomerulonephritis Treatment (Volume and Value) by Type
        2.2.1 Global Glomerulonephritis Treatment Sales and Market Share by Type (2012-2017)
        2.2.2 Global Glomerulonephritis Treatment Revenue and Market Share by Type (2012-2017)
    2.3 Global Glomerulonephritis Treatment (Volume and Value) by Region
        2.3.1 Global Glomerulonephritis Treatment Sales and Market Share by Region (2012-2017)
        2.3.2 Global Glomerulonephritis Treatment Revenue and Market Share by Region (2012-2017)
    2.4 Global Glomerulonephritis Treatment (Volume) by Application

3 United States Glomerulonephritis Treatment (Volume, Value and Sales Price)
    3.1 United States Glomerulonephritis Treatment Sales and Value (2012-2017)
        3.1.1 United States Glomerulonephritis Treatment Sales and Growth Rate (2012-2017)
        3.1.2 United States Glomerulonephritis Treatment Revenue and Growth Rate (2012-2017)
        3.1.3 United States Glomerulonephritis Treatment Sales Price Trend (2012-2017)
    3.2 United States Glomerulonephritis Treatment Sales Volume and Market Share by Players
    3.3 United States Glomerulonephritis Treatment Sales Volume and Market Share by Type
    3.4 United States Glomerulonephritis Treatment Sales Volume and Market Share by Application

4 China Glomerulonephritis Treatment (Volume, Value and Sales Price)
    4.1 China Glomerulonephritis Treatment Sales and Value (2012-2017)
        4.1.1 China Glomerulonephritis Treatment Sales and Growth Rate (2012-2017)
        4.1.2 China Glomerulonephritis Treatment Revenue and Growth Rate (2012-2017)
        4.1.3 China Glomerulonephritis Treatment Sales Price Trend (2012-2017)
    4.2 China Glomerulonephritis Treatment Sales Volume and Market Share by Players
    4.3 China Glomerulonephritis Treatment Sales Volume and Market Share by Type
    4.4 China Glomerulonephritis Treatment Sales Volume and Market Share by Application

5 Europe Glomerulonephritis Treatment (Volume, Value and Sales Price)
    5.1 Europe Glomerulonephritis Treatment Sales and Value (2012-2017)
        5.1.1 Europe Glomerulonephritis Treatment Sales and Growth Rate (2012-2017)
        5.1.2 Europe Glomerulonephritis Treatment Revenue and Growth Rate (2012-2017)
        5.1.3 Europe Glomerulonephritis Treatment Sales Price Trend (2012-2017)
    5.2 Europe Glomerulonephritis Treatment Sales Volume and Market Share by Players
    5.3 Europe Glomerulonephritis Treatment Sales Volume and Market Share by Type
    5.4 Europe Glomerulonephritis Treatment Sales Volume and Market Share by Application

6 Japan Glomerulonephritis Treatment (Volume, Value and Sales Price)
    6.1 Japan Glomerulonephritis Treatment Sales and Value (2012-2017)
        6.1.1 Japan Glomerulonephritis Treatment Sales and Growth Rate (2012-2017)
        6.1.2 Japan Glomerulonephritis Treatment Revenue and Growth Rate (2012-2017)
        6.1.3 Japan Glomerulonephritis Treatment Sales Price Trend (2012-2017)
    6.2 Japan Glomerulonephritis Treatment Sales Volume and Market Share by Players
    6.3 Japan Glomerulonephritis Treatment Sales Volume and Market Share by Type
    6.4 Japan Glomerulonephritis Treatment Sales Volume and Market Share by Application

7 Southeast Asia Glomerulonephritis Treatment (Volume, Value and Sales Price)
    7.1 Southeast Asia Glomerulonephritis Treatment Sales and Value (2012-2017)
        7.1.1 Southeast Asia Glomerulonephritis Treatment Sales and Growth Rate (2012-2017)
        7.1.2 Southeast Asia Glomerulonephritis Treatment Revenue and Growth Rate (2012-2017)
        7.1.3 Southeast Asia Glomerulonephritis Treatment Sales Price Trend (2012-2017)
    7.2 Southeast Asia Glomerulonephritis Treatment Sales Volume and Market Share by Players
    7.3 Southeast Asia Glomerulonephritis Treatment Sales Volume and Market Share by Type
    7.4 Southeast Asia Glomerulonephritis Treatment Sales Volume and Market Share by Application

8 India Glomerulonephritis Treatment (Volume, Value and Sales Price)
    8.1 India Glomerulonephritis Treatment Sales and Value (2012-2017)
        8.1.1 India Glomerulonephritis Treatment Sales and Growth Rate (2012-2017)
        8.1.2 India Glomerulonephritis Treatment Revenue and Growth Rate (2012-2017)
        8.1.3 India Glomerulonephritis Treatment Sales Price Trend (2012-2017)
    8.2 India Glomerulonephritis Treatment Sales Volume and Market Share by Players
    8.3 India Glomerulonephritis Treatment Sales Volume and Market Share by Type
    8.4 India Glomerulonephritis Treatment Sales Volume and Market Share by Application

9 Global Glomerulonephritis Treatment Players/Suppliers Profiles and Sales Data
    9.1 Achillion Pharmaceuticals Inc
        9.1.1 Company Basic Information, Manufacturing Base and Competitors
        9.1.2 Glomerulonephritis Treatment Product Category, Application and Specification
            9.1.2.1 Product A
            9.1.2.2 Product B
        9.1.3 Achillion Pharmaceuticals Inc Glomerulonephritis Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
        9.1.4 Main Business/Business Overview
    9.2 Anthera Pharmaceuticals Inc
        9.2.1 Company Basic Information, Manufacturing Base and Competitors
        9.2.2 Glomerulonephritis Treatment Product Category, Application and Specification
            9.2.2.1 Product A
            9.2.2.2 Product B
        9.2.3 Anthera Pharmaceuticals Inc Glomerulonephritis Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
        9.2.4 Main Business/Business Overview
    9.3 Biogen Inc
        9.3.1 Company Basic Information, Manufacturing Base and Competitors
        9.3.2 Glomerulonephritis Treatment Product Category, Application and Specification
            9.3.2.1 Product A
            9.3.2.2 Product B
        9.3.3 Biogen Inc Glomerulonephritis Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
        9.3.4 Main Business/Business Overview
    9.4 Bristol-Myers Squibb Company
        9.4.1 Company Basic Information, Manufacturing Base and Competitors
        9.4.2 Glomerulonephritis Treatment Product Category, Application and Specification
            9.4.2.1 Product A
            9.4.2.2 Product B
        9.4.3 Bristol-Myers Squibb Company Glomerulonephritis Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
        9.4.4 Main Business/Business Overview
    9.5 Cellmid Ltd
        9.5.1 Company Basic Information, Manufacturing Base and Competitors
        9.5.2 Glomerulonephritis Treatment Product Category, Application and Specification
            9.5.2.1 Product A
            9.5.2.2 Product B
        9.5.3 Cellmid Ltd Glomerulonephritis Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
        9.5.4 Main Business/Business Overview
    9.6 ChemoCentryx Inc
        9.6.1 Company Basic Information, Manufacturing Base and Competitors
        9.6.2 Glomerulonephritis Treatment Product Category, Application and Specification
            9.6.2.1 Product A
            9.6.2.2 Product B
        9.6.3 ChemoCentryx Inc Glomerulonephritis Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
        9.6.4 Main Business/Business Overview
    9.7 Complexa Inc
        9.7.1 Company Basic Information, Manufacturing Base and Competitors
        9.7.2 Glomerulonephritis Treatment Product Category, Application and Specification
            9.7.2.1 Product A
            9.7.2.2 Product B
        9.7.3 Complexa Inc Glomerulonephritis Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
        9.7.4 Main Business/Business Overview
    9.8 Dimerix Bioscience Pty Ltd
        9.8.1 Company Basic Information, Manufacturing Base and Competitors
        9.8.2 Glomerulonephritis Treatment Product Category, Application and Specification
            9.8.2.1 Product A
            9.8.2.2 Product B
        9.8.3 Dimerix Bioscience Pty Ltd Glomerulonephritis Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
        9.8.4 Main Business/Business Overview
    9.9 GlaxoSmithKline Plc
        9.9.1 Company Basic Information, Manufacturing Base and Competitors
        9.9.2 Glomerulonephritis Treatment Product Category, Application and Specification
            9.9.2.1 Product A
            9.9.2.2 Product B
        9.9.3 GlaxoSmithKline Plc Glomerulonephritis Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
        9.9.4 Main Business/Business Overview
    9.10 Merck KGaA
        9.10.1 Company Basic Information, Manufacturing Base and Competitors
        9.10.2 Glomerulonephritis Treatment Product Category, Application and Specification
            9.10.2.1 Product A
            9.10.2.2 Product B
        9.10.3 Merck KGaA Glomerulonephritis Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
        9.10.4 Main Business/Business Overview
    9.11 Omeros Corp
    9.12 Pfizer Inc
    9.13 Pharmalink AB
    9.14 Ra Pharmaceuticals Inc
    9.15 Retrophin Inc
    9.16 Rigel Pharmaceuticals Inc
    9.17 Shire Plc
    9.18 Visterra Inc

10 Glomerulonephritis Treatment Maufacturing Cost Analysis
    10.1 Glomerulonephritis Treatment Key Raw Materials Analysis
        10.1.1 Key Raw Materials
        10.1.2 Price Trend of Key Raw Materials
        10.1.3 Key Suppliers of Raw Materials
        10.1.4 Market Concentration Rate of Raw Materials
    10.2 Proportion of Manufacturing Cost Structure
        10.2.1 Raw Materials
        10.2.2 Labor Cost
        10.2.3 Manufacturing Process Analysis of Glomerulonephritis Treatment
    10.3 Manufacturing Process Analysis of Glomerulonephritis Treatment

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
    11.1 Glomerulonephritis Treatment Industrial Chain Analysis
    11.2 Upstream Raw Materials Sourcing
    11.3 Raw Materials Sources of Glomerulonephritis Treatment Major Manufacturers in 2016
    11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
    12.1 Marketing Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
        12.1.3 Marketing Channel Development Trend
    12.2 Market Positioning
        12.2.1 Pricing Strategy
        12.2.2 Brand Strategy
        12.2.3 Target Client
    12.3 Distributors/Traders List

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes Threat
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs/Customer Preference Change
    13.3 Economic/Political Environmental Change

14 Global Glomerulonephritis Treatment Market Forecast (2017-2022)
    14.1 Global Glomerulonephritis Treatment Sales Volume, Revenue and Price Forecast (2017-2022)
       14.1.1 Global Glomerulonephritis Treatment Sales Volume and Growth Rate Forecast (2017-2022)
       14.1.2 Global Glomerulonephritis Treatment Revenue and Growth Rate Forecast (2017-2022)
       14.1.3 Global Glomerulonephritis Treatment Price and Trend Forecast (2017-2022)
    14.2 Global Glomerulonephritis Treatment Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
       14.2.1 Global Glomerulonephritis Treatment Sales Volume and Growth Rate Forecast by Regions (2017-2022)
       14.2.2 Global Glomerulonephritis Treatment Revenue and Growth Rate Forecast by Regions (2017-2022)
       14.2.3 United States Glomerulonephritis Treatment Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.4 China Glomerulonephritis Treatment Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.5 Europe Glomerulonephritis Treatment Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.6 Japan Glomerulonephritis Treatment Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.7 Southeast Asia Glomerulonephritis Treatment Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.8 India Glomerulonephritis Treatment Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
    14.3 Global Glomerulonephritis Treatment Sales Volume, Revenue and Price Forecast by Type (2017-2022)
       14.3.1 Global Glomerulonephritis Treatment Sales Forecast by Type (2017-2022)
       14.3.2 Global Glomerulonephritis Treatment Revenue Forecast by Type (2017-2022)
       14.3.3 Global Glomerulonephritis Treatment Price Forecast by Type (2017-2022)
    14.4 Global Glomerulonephritis Treatment Sales Volume Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology/Research Approach
        16.1.1 Research Programs/Design
        16.1.2 Market Size Estimation
        16.1.3 Market Breakdown and